Targeted radioisotope generator could be used for molecular imaging
According to a study presented at SNM's 57th Annual Meeting, a new radioisotope generator could enhance images produced by a molecular imaging technique known as positron emission tomography (PET). The generator, in combination with instant synthesis kits that introduce target constituents like peptides to the mix, could be used to produce molecular imaging agents that enhance the range of targeting capabilities in diagnostic scans, providing physicians with a much broader portrait of how biological processes are working and why. "This generator is one more advanced technology that can improve the treatment of cancer, cardiovascular conditions and other common conditions," said Jeffrey Lacy, Ph.D., president of Houston-based Proportional Technologies, Inc. "For example, this technology has been shown to be especially effective for measuring myocardial blood flow and renal function.
Physicians could use this technology to more precisely evaluate blood flow through blood vessels and vital tissues, as well as more accurately target treatment for a broad range of cancers."
Using this generator, physicians would be able to inject peptide-labeled agents containing extremely small levels of the targeting peptide, which homes in on biological processes in the body. Only a small number of PET imaging agents are currently available due to their short half-lives, which require daily production and synthesis at more than 100 radiopharmacies across the country. The new generator would depend on a longer-lived parent isotope (9.3 hr Zn-62) that is relatively easily distributed and obtained, and physicians synthesize and inject the subsequent Cu-62, a copper-based agent, in a matter of minutes prior to scanning.
In this study, investigators miniaturized and redesigned components of a larger-scale generator approved for human investigational studies and tested the system for peptide specific activity using a peptide that targets a melanoma receptor called melanoma-1. Melanoma-bearing mice were injected with the peptide-labeled imaging agent and underwent PET imaging. Tumors showed rapid receptor-specific uptake of the agent with specific activity as high as 200 Ci/umol (a measurement of radioactivity in microcuries per micromolar concentration). Results showed that the generator and kit system was able to instantly label the radioactive copper isotope without further purification. The agent produced by this system has been shown to be favorable to human studies, and may improve upon the image quality of similar copper-based agents.
Source: Society of Nuclear Medicine
Articles on the same topic
- Radioactive optical imaging and 'quantum dot' nano-imaging at the forefront of molecular medicineMon, 7 Jun 2010, 22:05:45 UTC
- Molecular imaging can improve effectiveness of novel therapy for advanced heart diseaseMon, 7 Jun 2010, 18:15:18 UTC
- Feet first: Molecular imaging helps diagnose diabetic foot infectionMon, 7 Jun 2010, 18:15:16 UTC
- Molecular imaging prototype looks deep into soft tissues of the brain and other organsMon, 7 Jun 2010, 18:15:14 UTC
- Molecular imaging agent coupled with 'motion frozen' processing improves heart imagingMon, 7 Jun 2010, 18:15:13 UTC
- Molecular imaging 'probes' pinpoint prostate cancerMon, 7 Jun 2010, 18:15:12 UTC
- Molecular imaging allows individualized 'dose painting' for head and neck cancersMon, 7 Jun 2010, 18:15:02 UTC
- Molecular imaging helps predict breast cancer survivalMon, 7 Jun 2010, 18:14:55 UTC
- Molecular imaging may be best for capturing renal transplant complicationsMon, 7 Jun 2010, 18:14:51 UTC
- Blood-sugar lowering medications may increase risk for false positive results in cancer screeningsMon, 7 Jun 2010, 18:14:50 UTC
- Molecular imaging detects recurrent prostate cancerMon, 7 Jun 2010, 4:25:24 UTC
Other sources
- Molecular imaging can improve effectiveness of novel therapy for advanced heart diseasefrom PhysorgTue, 8 Jun 2010, 3:10:47 UTC
- Molecular imaging agent coupled with 'motion frozen' processing improves heart imagingfrom PhysorgMon, 7 Jun 2010, 21:52:26 UTC
- Radioactive optical imaging and 'quantum dot' nano-imaging at the forefront of molecular medicinefrom PhysorgMon, 7 Jun 2010, 21:51:57 UTC
- Molecular imaging detects recurrent prostate cancerfrom Biology News NetMon, 7 Jun 2010, 21:10:53 UTC
- Molecular imaging 'probes' pinpoint prostate cancerfrom PhysorgMon, 7 Jun 2010, 20:43:45 UTC
- Feet first: Molecular imaging helps diagnose diabetic foot infectionfrom PhysorgMon, 7 Jun 2010, 20:43:23 UTC
- Targeted radioisotope generator could be used for molecular imagingfrom PhysorgMon, 7 Jun 2010, 17:31:46 UTC
- Blood-sugar lowering medications may increase risk for false positive results in cancer screeningsfrom PhysorgMon, 7 Jun 2010, 17:31:34 UTC
- New molecular imaging agent may help visualize early stages of Alzheimer's diseasefrom PhysorgMon, 7 Jun 2010, 17:31:32 UTC
- Molecular imaging helps predict breast cancer survivalfrom PhysorgMon, 7 Jun 2010, 17:31:31 UTC
- Molecular imaging may be best for capturing renal transplant complicationsfrom PhysorgMon, 7 Jun 2010, 17:31:23 UTC
- Molecular imaging detects recurrent prostate cancerfrom PhysorgMon, 7 Jun 2010, 4:20:51 UTC